Icrucumab (IMC-18F1) is a human IgG1 monoclonal antibody that targets VEGFR-1 (FLT1). This antibody exhibits potential utility in the research of advanced solid tumors, providing a critical tool for investigating the role of VEGFR-1 in tumor angiogenesis and progression.
Icrucumab (IMC-18F1) is a human IgG1 monoclonal antibody that targets VEGFR-1 (FLT1). This antibody exhibits potential utility in the research of advanced solid tumors, providing a critical tool for investigating the role of VEGFR-1 in tumor angiogenesis and progression.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
